series-a
Stage
3
Investors
About
Xsensio develops a Lab-on-Skin™ biochemical sensing platform with miniaturized sensing chips for continuous, real-time monitoring of biomarkers such as inflammation to enable earlier detection of organ dysfunction in clinical and home settings.
Explore Xsensio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.